These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Infrared functional imaging applied to Raynaud's phenomenon. Merla A; Di Donato L; Di Luzio S; Farina G; Pisarri S; Proietti M; Salsano F; Romani GL IEEE Eng Med Biol Mag; 2002; 21(6):73-9. PubMed ID: 12613214 [No Abstract] [Full Text] [Related]
5. Role of cold and emotional stress in Raynaud's disease and scleroderma. Freedman RR; Ianni P Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474 [TBL] [Abstract][Full Text] [Related]
6. Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis. Herrick AL; Clark S Ann Rheum Dis; 1998 Feb; 57(2):70-8. PubMed ID: 9613334 [No Abstract] [Full Text] [Related]
7. [Capillaroscopy of the nail fold in Raynaud's phenomenon and scleroderma]. Knobel H; Vilardell M; Marquet R; Ordi J Med Clin (Barc); 1987 Oct; 89(13):533-6. PubMed ID: 3695683 [No Abstract] [Full Text] [Related]
10. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon. Seibold JR; Harris JN J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093 [TBL] [Abstract][Full Text] [Related]
11. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory. Czirják L; Matucci-Cerinic M Rheumatology (Oxford); 2011 Feb; 50(2):250-1. PubMed ID: 21115465 [No Abstract] [Full Text] [Related]
13. Clinical and physiological studies of Raynaud's phenomenon. Engelhart M Dan Med Bull; 1991 Dec; 38(6):458-68. PubMed ID: 1802635 [No Abstract] [Full Text] [Related]
14. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis. O'Reilly D; Taylor L; el-Hadidy K; Jayson MI Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594 [TBL] [Abstract][Full Text] [Related]
15. [Raynaud's disease - physiopathology and new aspects of treatment]. Znamirowska D Pol Tyg Lek; 1980 Jun; 35(25):957-9. PubMed ID: 7422584 [No Abstract] [Full Text] [Related]
16. Raising awareness of Raynaud's phenomenon and scleroderma. Mawdsley AH; Brown SJ Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937 [TBL] [Abstract][Full Text] [Related]
17. Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon. Flavahan NA Rheum Dis Clin North Am; 2008 Feb; 34(1):81-7; vii. PubMed ID: 18329534 [TBL] [Abstract][Full Text] [Related]
18. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study. Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479 [TBL] [Abstract][Full Text] [Related]
19. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon. Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666 [TBL] [Abstract][Full Text] [Related]
20. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders. Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]